Serplulimab Earns UK Approval in Extensive-Stage Small Cell Lung Cancer
The new lung cancer solution, Serplulimab, has gained UK approval
The core focus: Other cancer treatments and related clinical trials.
FDA Issues Partial Clinical Hold on Lorigerlimab Trial in Gynecologic Cancers
A safety concern has led the FDA to issue a partial clinical hold on the Lorigerlimab trial intended for gynecologic cancer treatment. Trial phases will be examined.
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma
Efforts are being applied towards improved management strategies dealing with the side effects of a melanoma treatment. Better patient care is on the horizon.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma
Positive news as FDA has granted fast track designation to SRN-101, a trustworthy option for treating high-grade glioma.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma
Encouraging early results have been observed from a novel small molecule treatment for multiple myeloma.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC
Two methods of treatment for oropharyngeal cancer are under comparison to discern the forerunner in betterment of patient life quality.
